-----BEGIN PGP SIGNED MESSAGE-----
AUSCERT External Security Bulletin Redistribution
Advisory (icsma-22-263-01) Medtronic NGP 600 Series Insulin Pumps
21 September 2022
AusCERT Security Bulletin Summary
Product: Medtronic NGP 600 Series Insulin Pumps
Operating System: Network Appliance
CVE Names: CVE-2022-32537
Comment: CVSS (Max): 4.8 CVE-2022-32537 (CVSS:3.0/AV:A/AC:H/PR:L/UI:N/S:U/C:N/I:H/A:N)
CVSS Source: ICS-CERT
- --------------------------BEGIN INCLUDED TEXT--------------------
ICS Medical Advisory (ICSMA-22-263-01)
Medtronic NGP 600 Series Insulin Pumps
Original release date: September 20, 2022
All information products included in https://us-cert.cisa.gov/ics are provided
"as is" for informational purposes only. The Department of Homeland Security
(DHS) does not provide any warranties of any kind regarding any information
contained within. DHS does not endorse any commercial product or service,
referenced in this product or otherwise. Further dissemination of this product
is governed by the Traffic Light Protocol (TLP) marking in the header. For more
information about TLP, see https://us-cert.cisa.gov/tlp/ .
1. EXECUTIVE SUMMARY
o CVSS v3 4.8
o ATTENTION: Exploitable from an adjacent network
o Vendor: Medtronic
o Equipment: MiniMed 600 Series Insulin Pumps, Guardian Link 3 Transmitter,
Guardian 2 Link Transmitter, Carelink USB, Contour Next Link 2.4
o Vulnerability: Protection Mechanism Failure
2. RISK EVALUATION
Successful exploitation of this vulnerability could allow an unauthorized user
to deliver too much or too little insulin through delivery of an unintended
insulin bolus or because insulin delivery is slowed or stopped.
3. TECHNICAL DETAILS
3.1 AFFECTED PRODUCTS
The following versions of the Medtronic NGP 600 Series Insulin Pumps and
accessory components are affected:
o MiniMed 620G: MMT-1710
o MiniMed 630G: MMT-1715, MMT-1754, MMT-1755
o MiniMed 640G: MMT-1711, MMT-1712, MMT-1751, MMT-1752
o MiniMed 670G: MMT-1740, MMT-1741, MMT-1742, MMT-1760, MMT-1762, MMT-1762,
MMT-1780, MMT-1781, MMT-1782
3.2 VULNERABILITY OVERVIEW
3.2.1 PROTECTION MECHANISM FAILURE CWE-693
A vulnerability exists which could allow an unauthorized user to learn aspects
of the communication protocol used to pair system components while the pump is
being paired with other system components. Exploitation requires nearby
wireless signal proximity with the patient and the device; advanced technical
knowledge is required for exploitation.
CVE-2022-32537 has been assigned to this vulnerability. A CVSS v3 base score of
4.8 has been calculated; the CVSS vector string is ( AV:A/AC:H/PR:L/UI:N/S:U/
o CRITICAL INFRASTRUCTURE SECTORS: Healthcare and Public Health
o COUNTRIES/AREAS DEPLOYED: Worldwide
o COMPANY HEADQUARTERS LOCATION: Ireland
Medtronic internally identified and reported this vulnerability to CISA.
Medtronic recommends users to take the following actions:
1. Turn off the "Remote Bolus" feature on the pump.
2. Only connect or link devices in a private place.
Note: Turning off the remote bolus feature will ensure no remote bolus is
Medtronic has identified the following precautions to assist users:
o Ensure the pump and connected system components are always controlled by an
o Be attentive to pump notifications, alarms, and alerts.
o Immediately cancel any boluses not initiated by authorized personnel;
monitor blood glucose levels closely and reach out to Medtronic 24-Hour
Technical Support to report the bolus.
o Disconnect the USB device from the computer when not downloading pump data.
o Users should not confirm remote connection requests or any other remote
action on the pump screen unless it is initiated by authorized care
o Avoid sharing pump or device serial numbers with anyone other than the
healthcare provider, distributors, and Medtronic.
o Users should not accept, calibrate, or bolus using a blood glucose reading
not initiated by authorized care personnel.
o Users should not connect to or allow any third-party devices to connect to
o Do not use software not authorized by Medtronic as being safe for use with
o Medtronic advises patients experiencing symptoms of severe hypoglycemia or
diabetic ketoacidosis to seek immediate medical attention.
o Users are encouraged to reach out to Medtronic 24-Hour Technical Support
(1-800-646-4633) if they suspect a pump setting or insulin delivery have
changed unexpectedly, without proper knowledge.
CISA reminds organizations to perform proper impact analysis and risk
assessment prior to deploying defensive measures.
CISA also provides a section for control systems security recommended practices
on the ICS webpage at cisa.gov/ics . Several CISA products detailing cyber
defense best practices are available for reading and download, including
Improving Industrial Control Systems Cybersecurity with Defense-in-Depth
Additional mitigation guidance and recommended practices are publicly available
on the ICS webpage at cisa.gov/ics in the technical information paper,
ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation
Organizations observing suspected malicious activity should follow established
internal procedures and report findings to CISA for tracking and correlation
against other incidents.
No known public exploits specifically target this vulnerability. This
vulnerability has a high attack complexity.
For any questions related to this report, please contact the CISA at:
Toll Free: 1-888-282-0870
CISA continuously strives to improve its products and services. You can help by
choosing one of the links below to provide feedback about this product.
- --------------------------END INCLUDED TEXT--------------------
You have received this e-mail bulletin as a result of your organisation's
registration with AusCERT. The mailing list you are subscribed to is
maintained within your organisation, so if you do not wish to continue
receiving these bulletins you should contact your local IT manager. If
you do not know who that is, please send an email to firstname.lastname@example.org
and we will forward your request to the appropriate person.
NOTE: Third Party Rights
This security bulletin is provided as a service to AusCERT's members. As
AusCERT did not write the document quoted above, AusCERT has had no control
over its content. The decision to follow or act on information or advice
contained in this security bulletin is the responsibility of each user or
organisation, and should be considered in accordance with your organisation's
site policies and procedures. AusCERT takes no responsibility for consequences
which may arise from following or acting on information or advice contained in
this security bulletin.
NOTE: This is only the original release of the security bulletin. It may
not be updated when updates to the original are made. If downloading at
a later date, it is recommended that the bulletin is retrieved directly
from the author's website to ensure that the information is still current.
Contact information for the authors of the original document is included
in the Security Bulletin above. If you have any questions or need further
information, please contact them directly.
Previous advisories and external security bulletins can be retrieved from:
Australian Computer Emergency Response Team
The University of Queensland
Internet Email: email@example.com
Facsimile: (07) 3365 7031
Telephone: (07) 3365 4417 (International: +61 7 3365 4417)
AusCERT personnel answer during Queensland business hours
which are GMT+10:00 (AEST).
On call after hours for member emergencies only.
-----BEGIN PGP SIGNATURE-----
-----END PGP SIGNATURE-----